Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Artivion, Inc.

https://artivion.com/

Latest From Artivion, Inc.

China Approves World’s First Inhaled COVID-19 Vaccine

China has cleared for sale the world's first inhaled vaccine for COVID-19, as China continues to face challenges to its strict "COVID Zero" policies, including a new extended lockdown in a major city, ahead of the upcoming high-stakes National Congress. 

China Coronavirus COVID-19

Bayer's High Hopes For Huntington's Gene Therapy As Novartis’s Branaplam Stumbles

When the German major bought AskBio a couple of years ago, one of its assets was a gene therapy for Huntington’s, a devastating disease that leads to complete physical and mental deterioration. That asset, BV-101, is about to enter the clinic.

Gene Therapy Neurology

Medtechs Drive To Keep The Status Quo In A Year Like No Other

The performances of the leading medtechs in the first year of the COVID-19 pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management skills and planning.

Outlook 2022 Commercial

MTI 100 Review: Medtechs Drive To Keep The Status Quo In A Year Like No Other

The performances of the leading medtechs in the first year of the COVID pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management's planning skills.

Commercial Sales & Earnings
See All

Company Information

  • Industry
  • Biotechnology
  • Distributors
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Other Names / Subsidiaries
    • CryoLife, Inc.
    • Cardiogenesis Corporation
    • CryoLife Asia Pacific, Pte. Ltd.
    • CryoLife Europa Ltd
    • CryoLife France, SAS
    • JOTEC AG
    • JOTEC Cardiovascular SL.
    • JOTEC Polska Sp. z o.o.
    • JOTEC s.r.l.
    • On-X Life Technologies Holdings, Inc.
    • Ascyrus Medical LLC
UsernamePublicRestriction

Register